Patent details

EP1948158 Title: PHARMACEUTICAL COMBINATIONS OF AN ANGIOTENSIN RECEPTOR ANTAGONIST AND AN NEP INHIBITOR

Basic Information

Publication number:
EP1948158
PCT Application Number:
PCT/US/2006/043710
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP068276898
PCT Publication Number:
WO/2007/056546
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMBINATIONS OF AN ANGIOTENSIN RECEPTOR ANTAGONIST AND AN NEP INHIBITOR
French Title of Invention:
COMBINAISON PHARMACEUTIQUES D'UN ANTAGONISTE DE RECEPTEUR D'ANGIOTENSINE ET D'UN INHIBITEUR DE NEP
German Title of Invention:
PHARMAZEUTISCHE KOMBINATIONEN AUS EINEM ANGIOTENSINREZEPTOR-ANTAGONISTEN UND NEP-HEMMER
SPC Number:
93075

Dates

Filing date:
08/11/2006
Grant date:
29/01/2014
EP Publication Date:
29/01/2014
PCT Publication Date:
18/05/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/07/2008
EP B1 Publication Date:
29/01/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/11/2026
Renunciation date:
Revocation date:
28/06/2023
Annulment date:

Owner

From:
27/05/2016
 
 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/05/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HU Bin
Address:
United States (US)

2

Name:
SUTTON Paul, Allen
Address:
United States (US)

3

Name:
GIRGIS Michael, J.
Address:
United States (US)

4

Name:
FENG Lili
Address:
United States (US)

5

Name:
KARPINSKI Piotr
Address:
United States (US)

6

Name:
PRASHAD Mahavir
Address:
United States (US)

7

Name:
BLACKLOCK Thomas, J.
Address:
United States (US)

8

Name:
LIU Yugang
Address:
United States (US)

9

Name:
GODTFREDSEN Sven, Erik
Address:
United States (US)

Priority

1

Priority Number:
735093 P
Priority Date:
09/11/2005
Priority Country:
United States (US)

2

Priority Number:
735541 P
Priority Date:
10/11/2005
Priority Country:
United States (US)

3

Priority Number:
789332 P
Priority Date:
04/04/2006
Priority Country:
United States (US)

4

Priority Number:
822086 P
Priority Date:
11/08/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/216;

Publication

Bulletin

1

Bulletin Heading:
VB2
Bulletin edition number:
2022/03
Publication date:
02/02/2022
Description:
Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

2

Bulletin Heading:
VRV
Bulletin edition number:
2023/08
Publication date:
03/07/2023
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
202144
Publication date:
03/11/2021
Description:
Opposition rejected; Patent maintained as granted

2

Issue number:
202326
Publication date:
28/06/2023
Description:
Decision on revocation request

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/10/2022
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages